UPC APP 44663/2024

—·EP4070727: DISPLAYS FOR A MEDICAL DEVICE

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Verfahrensführungsanordnungen
Parteien: Kläger
DexCom, Inc.
Dexcom International Limited
Vertreter: Tjibbe Douma
Beklagte
Abbott Diabetes Care Inc.
Vertreter: Eelco Bergsma
Division: The Hague LD
Richter: Edger Brinkman · Judge-rapporteur
Technology: Healthcare Informatics
Sprache: —
Erste Entscheidung: 17. Sept. 2024

Entscheidungen

2024-09-17
Amend Document
The Hague Local Division considered Dexcom's application to amend its counterclaim for revocation to add a declaration of non-infringement claim regarding the G7-System used with the G7-Receiver, following Abbott's partial withdrawal of its infringement claim (i.e. Abbott maintained infringement only for the G7-System with the G7-App, not the G7-Receiver).
Rechtsfragen:Amendment of counterclaim for revocationNon-infringement declaration in counterclaimPartial withdrawal of infringement claim by claimant

Dokumente